{
	"type": "rich",
	"version": "1.0",
	"provider_name": "Action Network",
	"provider_url": "https://actionnetwork.org",
	
	"html": "<link href='https://actionnetwork.org/css/style-embed-v3.css' rel='stylesheet' type='text/css' /><script src='https://actionnetwork.org/widgets/v6/letter/tell-congress-extend-the-35-insulin-cap?format=js&source=widget'></script><div id='can-letter-area-tell-congress-extend-the-35-insulin-cap' style='width: 100%'><!-- this div is the target for our HTML insertion --></div>",
	"author_name": "Patients For Affordable Drugs",
	"author_url": "https://actionnetwork.org/groups/patients-for-affordable-drugs",
	"title": "Tell Congress: Extend the $35 Insulin Cap",
	"thumbnail_url": "https://can2-prod.s3.amazonaws.com/letters/photos/000/454/445/normal/open-uri20260729-555825-1ehdz04",
	"description": "For people with diabetes, insulin is essential—not optional. Yet many Americans with private insurance continue to face high out-of-pocket costs for a medication they need to stay alive. Since 2023, Medicare beneficiaries have benefited from a $35 monthly cap on insulin costs, helping more than a million patients save money on their prescriptions. It&#x27;s time to extend that same protection to everyone who relies on insulin. The bipartisan INSULIN Act would establish a $35 monthly out-of-pocket cap for insulin for people with private insurance, helping make this lifesaving medication more affordable while reducing financial barriers to care. The Senate HELP Committee has already advanced this legislation. Now it&#x27;s up to Congress to keep the momentum going. The pharmaceutical industry is already lobbying to protect its interests. Lawmakers need to hear from the patients and families who depend on affordable insulin. Send a letter to your members of Congress today and urge them to pass the bipartisan INSULIN Act.",
	"url": "https://actionnetwork.org/letters/tell-congress-extend-the-35-insulin-cap/"
}